Ingested (oral) SST inhibits EAE

Autoimmunity

Volumn 44, Issue 5, 2011, Pages 437-443

  Brod, Staley A ^a   Hood, Zachary M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adoptive transfer; EAE; Oral proteins; Somatostatin; Th1 Th2; Th17

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; PLACEBO; SOMATOSTATIN;

ALLERGIC ENCEPHALITIS; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH1 CELL; TH17 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ADOPTIVE TRANSFER; ANIMALS; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; IMMUNIZATION; MICE; MICE, INBRED C57BL; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDES; SOMATOSTATIN; SPLEEN; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 79960113599     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2010.536796     Document Type: Article

References (30)

1. Alvord EC, Shaw CM, Huby S, Kies MK. Encephalitogeninduced inhibition of experimental allergic encephalomyelitis: Prevention, suppression, and therapy. AnnN YAcad Sci 1965; 122:333-345
2. Raine CS, Stone SH. Animal models for multiple sclerosis: Chronic experimental allergic encephalomyelitis in inbred guinea pigs. N Y State J Med 1977;77:1693-1696
3. Wisnewski HM, Keith AB. Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosis. Ann Neurol 1977;1:144-148
4. Feuer C, Prentice DE, Cammisuli S. Chronic relapsing experimental allergic encephalomyelitis in the lewis rat. J Neuroimmunol 1985;10:159-166 (Pubitemid 16205945)
5. Brod SA, Burns DK. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons. Neurology 1994;44: 1144-1148 (Pubitemid 24188192)
6. Brod SA, Hood Z. Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th(2)-like cytokines. J Neuroimmunol 2007;183:89-95 (Pubitemid 46204913)
7. Brod SA, Hood ZM. Ingested (oral) alpha-MSH inhibits acute EAE. J Neuroimmunol 2008;193:106-112
8. Brod SA, Khan M, Kerman RH, Pappolla M. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;58: 61-69
9. Brod SA, Khan M. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J Autoimmun 1996;9:11-20 (Pubitemid 26141888)
10. Ferone D, Boschetti M, Resmini E, Giusti M, Albanese V, Goglia U, Albertelli M, Vera L, Bianchi F, Minuto F. Neuroendocrine-immune interactions: The role of cortistatin/ somatostatin system. Ann N Y Acad Sci 2006;1069:129-144 (Pubitemid 43989856)
11. Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola E, Pivonello R, Albertelli M, Bianchi F, Giusti M, Minuto F. Potential indications for somatostatin analogues: Immune system and limphoproliferative disorders. J Endocrinol Invest 2005;28:111-117
12. ten Bokum AM, Hofland LJ, van Hagen PM. Somatostatin and somatostatin receptors in the immune system: A review. Eur Cytokine Netw 2000; 11: 161-176.
13. Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J Immunol 2002;168: 4173-4183 (Pubitemid 34298426)
14. Dong C. Diversification of T-helper-cell lineages: Finding the family root of IL-17-producing cells. Nat Rev Immunol 2006; 6:329-333
15. Gaffen SL, Kramer JM, Yu JJ, Shen F. The IL-17 cytokine family. Vitam Horm 2006;74:255-282
16. De Carli M, D?Elios MM, Zancuoghi G, Romagnani S, Del Prete G. Human Th1 and Th2 cells: Functional properties, regulation of development and role in autoimmunity. Autoimmunity 1994;18:301-308 (Pubitemid 24350979)
17. Kroemer G, Hirsch F, Gonzalez-Garcia A, Martinez C. Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 1996;24:25-33 (Pubitemid 26379164)
18. Brod SA, Khan M, Nelson LD, Decuir B, Malone M, Henninger E. Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion. J Immunother 2000;23: 235-245 (Pubitemid 30165173)
19. Malefyt R, Haanen J, Spits H, Roncarolo M-G, te Velde A, Figdor CG, de Vries JE. IL-10 and viral IL-10 strongly reduce antigen specific human T-cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II MHC expression. J Exp Med 1991;174:915-924
20. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, Freeman GJ, Kuchroo VK. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536-541 (Pubitemid 34130609)
21. Yu P, Gregg RK, Bell JJ, Ellis JS, Divekar R, Lee HH, Jain R, Waldner H, Hardaway JC, Collins M, Kuchroo VK, Zaghouani H. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol 2005;174:6772-6780 (Pubitemid 40705640)
22. Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, Delignat S, Elluru S, Bayry J, Lacroix-Desmazes S, Cohen JL, Salomon BL, Kazatchkine MD, Kaveri SV, Misra N. Expansion of CD4? CD25? regulatory T cells by intravenous immunoglobulin: A critical factor in controlling experimental autoimmune encephalomyelitis. Blood 2008; 111:715-722
23. Kohm AP, Carpentier PA, Miller SD. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4? CD25? regulatory T cells. Novartis Found Symp 2003;252:45-52; discussion -4, 106-114
24. Sun D, Whitaker JN, Wilson DB. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease. Int Immunol 1999;11:307-315 (Pubitemid 29121618)
25. Matsumoto Y, Sakuma H, Kohyama K, Park IK. Paralysis of CD4(?)CD25(?) regulatory T cell response in chronic autoimmune encephalomyelitis. J Neuroimmunol 2007;187: 44-54 (Pubitemid 47001536)
26. Lavasani S, Dzhambazov B, Nouri M, Fak F, Buske S, Molin G, Thorlacius H, Alenfall J, Jeppsson B, Westrom B. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010;5: e9009
27. Lichtenauer-Kaligis EG, van Hagen PM, Lamberts SW, Hofland LJ. Somatostatin receptor subtypes in human immune cells. Eur J Endocrinol 2000;143(Suppl 1):S21-S25
28. ten Bokum AM, Lichtenauer-Kaligis EG, Melief MJ, van Koetsveld PM, Bruns C, van Hagen PM, Hofland LJ, Lamberts SW, Hazenberg MP. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis. J Endocrinol 1999; 161: 167-175. (Pubitemid 29170203)
29. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 1998; 95:12544-12549 (Pubitemid 28483801)
30. Adorini L, Guery JC, Trembleau S. Manipulation of the Th1/ Th2 cell balance: An approach to treat human autoimmune diseases? Autoimmunity 1996;23:53-68 (Pubitemid 26335835)